CN1939406A - Danshen root drop pills for treating coronary heart disease and preparation thereof - Google Patents

Danshen root drop pills for treating coronary heart disease and preparation thereof Download PDF

Info

Publication number
CN1939406A
CN1939406A CNA2006101526679A CN200610152667A CN1939406A CN 1939406 A CN1939406 A CN 1939406A CN A2006101526679 A CNA2006101526679 A CN A2006101526679A CN 200610152667 A CN200610152667 A CN 200610152667A CN 1939406 A CN1939406 A CN 1939406A
Authority
CN
China
Prior art keywords
salviae miltiorrhizae
preparation
radix salviae
lignum dalbergiae
dalbergiae odoriferae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006101526679A
Other languages
Chinese (zh)
Inventor
刘凤鸣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2006101526679A priority Critical patent/CN1939406A/en
Publication of CN1939406A publication Critical patent/CN1939406A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

A dripping pill of red sage root, notoginseng and dalbergia wood is prepared from red sage root, notoginseng and dalbergia wood through proportional adding polyoxyvinyl monostearate, mixing, heating for fusing, stirring, and dripping in condensing liquid.

Description

Danshen root drop pills for treating coronary heart disease and preparation method thereof
[technical field] the present invention relates to a kind of medicine and preparation method thereof, particularly Danshen root drop pills for treating coronary heart disease and preparation method thereof.
[background technology]
Drop pill splashes in the immiscible condensed fluid after being meant solid or liquid medicine and substrate heat fused mixing, and condensation is shunk and the preparation made.Because medicine is with superfine microparticulate, and the one-tenth colloid disperses in solution, and becomes rapid dissolved amorphous mixture, can improve the drug oral bioavailability effectively.The Rue oil. drop pill of China with regard to going on the market in 1971 makes dropping pill formulation really become a kind of effective pharmaceutical dosage form.Drop pill can also can be made into sustained-release preparation for for oral administration, external and local the use, has brought into play and continued playing an important role in China's field of pharmaceutical preparations, is a kind of noticeable and the dosage form of good development prospect arranged.
Dropping pill formulation has the multiple advantage that is different from other peroral dosage forms, by selecting water-soluble base for use, control drug release rate or dissolve scattered time limit, can under the condition of quenching, form solid dispersion, medicine exists with atomic little microgranule, crystallite or molecularity, so can improve the dissolution rate and the bioavailability of insoluble drug, play quick-acting, effect efficiently; Select for use suitable controlled slowly releasing adjuncts or enteric solubility substrate to drip and make ball, can control the release of medicine, play the effect of slow release or enteric.Particularly, when its sustained-release preparation of preparation, can consider drops, thereby can in control drug release, increase bioavailability for some insoluble drugs or drugs with low bioavailability.The production equipment of dropping pill formulation is simple, processing ease, and weight differential is little, and production cost is low, and no dust is suitable for industrialized great production.Also facile hydrolysis, oxidation decomposition or volatile pharmaceutical pack can be embedded in wherein and increase stability of drug.
According to its preparation technology's difference, dropping pill formulation can be divided into quick-acting efficient drop pill, controlled release pill, enteric coated drop pill, coated drop pill, external-use drops, hard capsule drop pill, elaioplast drop ball etc.Used substrate is except fat-soluble substrate (as stearic acid, glyceryl monostearate, insect wax, hydrogenated vegetable oil, stearyl alcohol, spermol, semi-synthetic fatty acid ester etc.) and water-soluble base (as Polyethylene Glycol, sodium stearate, glycerin gelatine, carbamide, poloxamer etc.) commonly used, in recent years, there are some good polymeric materials to be developed substrate again as drop pill, and the more and more important effect of performance.Polyoxyethylene stearate 40 esters are a kind of nonionic surfactant, be usually used in preparing insoluble drug, solid dispersion as griseofulvin, tolbutamide and nalidixan etc., it has similar average molecular mass to PEG2000, and S-40 can promote dispersion, disintegrate, the stripping of medicine in solid dispersion and the effect that makes medicament solubilization.Along with being on the increase of substrate kind, preparation technology's is ripe day by day perfect, and drop pill is extensive day by day in the application of Chinese-western medicine preparation, therefore existing medicine is carried out modified form, produce more medicinal dropping ball dosage form, will greatly enrich drug market, improve quality of medical care.
Radix Salviae Miltiorrhizae (Radix Salviae Miltiorrhizae) is the dry root of labiate Radix Salviae Miltiorrhizae Salvia miltiorrhiza Bge..Bitter in the mouth, cold nature, function is blood circulation promoting and blood stasis dispelling, calming heart and tranquilizing mind, eliminating carbuncle pain relieving, cures mainly cards such as hematogenous blockage, thoracic obstruction angor, menoxenia, amenorrhea, dysmenorrhea, traumatic injury and palpitation with fear sleeplessness, ulcer sore pain.Mainly contain Tanshinone I, IIA, IIB (tanshinone I, IIA, IIB) iso tanshinone I, IIA (isotanshinone I, IIA), cryptotanshinone (cryptotanshinone), different cryptotanshinone (isocryptotanshin-one), methyltanshinone (methyItanshinone), hydroxyl TANSHINONES (hydroxytanshinone), dihydrotanshinone (dihydrotanshinone), miltirone (miltirone), neotanshinone A, second, third, fourth (danshexinkunA, B, C, D) Methyl tanshinoate (methyltanshexinkun), accurate TANSHINONES (nortanshinone), tanshinol I II III (tanshinol I II III), Tanshindiol A (tanshindiol A), 1,2-dihydro Radix Salviae Miltiorrhizae quinone (1,2-dihydrotanshinquinone) and Radix Salviae Miltiorrhizae aldehyde (tanshialdehyde), Radix Salviae Miltiorrhizae spiral ketone lactone compositions such as (danshenspiroketallactone), except that diterpene quinones composition, also contain liposoluble ingredient protocatechualdehyde (protocatechuic aldehyde), protocatechuic acid (protocatechuic acid), salviol (salviol), saivianic acid A, second, third (the salvianicacidA, B, C), salviol acid A (salvianolic acidA) and ursolic acid (ursolic acid), Hesperetic acids (isoferulic acid) etc. still have baicalin etc. in addition.
Radix Notoginseng (Radix Notoginseng) is the dry root of panax araliaceae plant Panax notoginseng (Burk.) F.H.Chen.Warm in nature, sweet in the mouth, little hardship.The dissipating blood stasis hemostasis, subduing swelling and relieving pain.Be used for various inside and outside hemorrhage, breast ventral spine pain, tumbling and swelling.Its Radix Notoginseng total arasaponins content is about 12%, is the main pharmacological component of Radix Notoginseng; Now from Radix Notoginseng, separate and obtain 20 kinds of dammarane (Dammarane) type Saponin, difference according to prosapogenin structure after the hydrolysis, be divided into ginsenoside (Ginsenoside) Rg, Rb, comprise: ginsenoside Rg1, Rg2, Rb1, Rb2, Rb3, Rc, Rd, Re, Rh, F2, arasaponin R1, arasaponin R2, arasaponin R3, arasaponin R6, arasaponin Fa, arasaponin Fc, arasaponin Fe, arasaponin R4 etc.; And contain Radix Notoginseng flavone A, Radix Notoginseng flavone B, volatile oil, alkaloid, polysaccharide, aminoacid-β-oxalyl group-L-a, β-diaminopropionic acid effective ingredient such as (deneichine).
Lignum Dalbergiae Odoriferae (Lignum Dalbergiae Odoriferae) belongs to leguminous plant Lignum Dalbergiae Odoriferae wingceltis Dalbergiaodorifera T.Chen.Contain main constituent dalbergin (Dalbergin) in volatile oil, the oil, Nordalbergin (Nordalbergin), isodalbergin (Isodalbergin), methyldalbergin (o-Methyldalbergin), dalbergenone (Dalbergenone) and dalbergichromene (Dalbergichromene).Gas chromatography shows and contains 12 kinds of compositions in the volatile oil of Lignum Dalbergiae Odoriferae at least, identified β-heerabolene (β-bisalolene), trans-β-farnesene [(trans)-β-farnesene] and trans-nerolidol [(trans)-nerolidol].
Radix Salviae Miltiorrhizae has following pharmacological action: 1. pair heart, cerebrovascular effect: liquid salvia can make the decreased heart rate of Cavia porcellus and rabbit isolated heart, and heart contractility has of short duration inhibition earlier, then strengthens gradually.The heart of anesthetized dog is slowed down.Radix Salviae Miltiorrhizae water extract 5g (medical material)/kg lumbar injection prevented 30 minutes, can prevent or reduce the generation that is caused rat ventricular fibrillation by isoproterenol, improved the survival of rats rate.Radix Salviae Miltiorrhizae decoct, Radix Salviae Miltiorrhizae Injection give anesthetized dog or the quiet notes of rabbit, all the hypotensive effect of showed different.The Radix Salviae Miltiorrhizae decoct has certain protective role to myocardial ischemia, experiment showed, that Radix Salviae Miltiorrhizae Injection can make the survival of rat implantation heart obviously prolong, and FUFANG DANSHEN JIAONANG has significant protective effect to experimental myocardial infarction, can treat angina pectoris effectively.2. to blood fat and atherosclerotic effect: the Radix Salviae Miltiorrhizae decoct is irritated stomach to atherosclerotic rabbit, but the triglyceride in the blood fat reducing regulating liver-QI.Radix Salviae Miltiorrhizae can suppress the formation of the big branch of rabbit experiment coronary artery atheromatous plaque.3. to Immune Effects: 100% Radix Salviae Miltiorrhizae decoct 0.5ml/ only irritates stomach, mouse macrophage phagocytic percentage and phagocytic index is obviously improved in continuous 7 days.Radix Salviae Miltiorrhizae also has anticoagulation, fibrinolysis enhancing, relievings asthma, antiinflammatory, antiallergic, promotion union of fracture, prevents effects such as hepatic injury and gonadal hormone sample in addition.
Radix Notoginseng has the protection heart, significantly improves myocardial oxygen delivery ability, vessel softening, improvement cardiac muscle microcirculation, increase coronary flow, prevent myocardial ischemia; Anti-arrhythmia, inhibition arteriosclerosis; Pharmacological actions such as blood pressure lowering, blood fat reducing, cholesterol reducing, two-ways regulation blood glucose.Be used to prevent, treat the disease for the treatment of cardiac and cerebral vascular diseases; To coronary heart disease, angina pectoris, arteriosclerosis, cerebral thrombosis, hypertension, hyperlipidemia, hyperglycemia, etc. disease, significant curative effect is arranged; And antiinflammatory, hemostasis, pain relieving, raising human body immunocompetence, antitumor action arranged.
Lignum Dalbergiae Odoriferae pharmacological action: 1, influence to blood system: Lignum Dalbergiae Odoriferae is a promoting blood circulation to remove blood stasis Chinese medicine, experiment shows that its syndrome of blood stasis animal capable that high molecular dextran is injected formed blood high viscosity syndrome significantly reduces whole blood viscosity, especially the whole blood viscosity effect is outstanding under the high shear rate to reduce, also can reduce plasma viscosity, but erythrocyte aggregation is not made significant difference, Lignum Dalbergiae Odoriferae also has the blood fat reducing effect, it reduces syndrome of blood stasis animal blood viscosity may be relevant with its effect for reducing fat, and the mechanism of its lipid-lowering effect is then with to suppress hydroxymethyl glutaryl (HMG) CoA-reductase relevant.2, to the influence of cardiovascular system: experiment shows that the single Lignum Dalbergiae Odoriferae can significantly promote the recovery of the experimental microcirculation disturbance blood flow of mice mesentery, and the recovery after the arteriole contraction and the recovery of local microcirculation, arteriolar contraction is stronger due to its antiadrenergic drug, to a little less than postponing the effect that blood arrheas.3, calm, anticonvulsant action.4, analgesic activity.5, other effects: Lignum Dalbergiae Odoriferae can suppress cholecystokinin receptor and purine invertase.
The GUANXIN DANSHEN PIAN of using clinically is tablet and capsule at present.Dropping pill formulation has characteristics such as bioavailability height, release fast, quick produce effects, is made into drop pill, in the hope of reaching the raising bioavailability, brings into play curative effect of medication more fully, reduces purposes such as untoward reaction.
[summary of the invention]
The purpose of this invention is to provide drops of a kind of GUANXIN DANSHEN PIAN and preparation method thereof.
The extract of Radix Salviae Miltiorrhizae 200g Radix Notoginseng 200g is pressed the Chinese Pharmacopoeia standard fabrication, adds Lignum Dalbergiae Odoriferae oil 1.75ml, then according to certain ratio, adds substrate such as surfactant polyethylene, is prepared from through specific technology, apparatus processing again.
The present invention studies by experiment GUANXIN DANSHEN PIAN has been carried out modified form, changes dropping pill formulation into from existing tablet, capsule.Utilize substrate such as surfactant polyethylene, polyoxyethylene monostearate, polyoxyethylene stearate 40 esters, polyethers and selected medicine material to make solid dispersion; making medicine be molecule, colloid or microcrystalline state is scattered in the substrate; the total surface area of medicine increases; and substrate is hydrophilic; medicine had wetting action; can make that medicine is rapidly molten to loose into microgranule or solution, thereby make the dissolving of medicine and absorb and accelerate.Thereby improved bioavailability and stability of drug, produced efficient, convenient etc. effect.
Wherein said dropping pill formulation is made up of Radix Salviae Miltiorrhizae, Radix Notoginseng extract, Lignum Dalbergiae Odoriferae oil and substrate, and wherein the weight ratio of Radix Salviae Miltiorrhizae, Radix Notoginseng extract, Lignum Dalbergiae Odoriferae oil and substrate is 1: 1~15.Described substrate includes Polyethylene Glycol (2000,4000,6000,8000,10000,20000), polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, stearic acid, sodium stearate, glycerin gelatine, glyceryl monostearate, Lac, polyoxyethylene monostearate, polyethers one or more composition.Substrate is following but be not limitation of the invention for more than one mixture of ingredients exemplify: polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 1~10; Betacyclodextrin: Polyethylene Glycol=1: 1~10; Poloxamer: Polyethylene Glycol=1: 1~10; Carboxymethyl starch sodium: Polyethylene Glycol=1: 1~10.
Wherein said drop pill can be made into common dropping pill formulation, also can be made into slow-release pill preparation, enteric coated drop pill preparation, coated drop pill preparation etc.
A kind of preparation method provided by the present invention is as follows:
With Radix Salviae Miltiorrhizae, Radix Notoginseng extract, Lignum Dalbergiae Odoriferae oil is primary raw material, according to certain ratio, adds substrate such as surfactant polyethylene, is prepared from through specific technology, apparatus processing again.Specific as follows:
(1) prescription: Radix Salviae Miltiorrhizae, Radix Notoginseng extract, Lignum Dalbergiae Odoriferae oil+substrate;
Substrate: include Polyethylene Glycol (2000,4000,6000,8000,10000,20000), polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, stearic acid, sodium stearate, glycerin gelatine, glyceryl monostearate, Lac, polyoxyethylene monostearate, polyethers one or more composition.
The weight ratio of Radix Salviae Miltiorrhizae, Radix Notoginseng extract, Lignum Dalbergiae Odoriferae oil and substrate is 1: 1~15;
(2) preparation technology: concrete implementation step is as follows:
The first step is mixed Radix Salviae Miltiorrhizae, Radix Notoginseng extract, Lignum Dalbergiae Odoriferae oil according to certain ratio with matrix phase; Substrate can be Polyethylene Glycol (2000,4000,6000,8000,10000,20000), in polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, stearic acid, sodium stearate, glycerin gelatine, glyceryl monostearate, Lac, polyoxyethylene monostearate, polyethers etc. any one or a few mix mutually.
Second step was adopted water-bath, oil bath or other mode of heating, and mixed material is heated to fusion, stirred.
The 3rd step inserted on the drop pill machine, and keeping temperature is 70~120 ℃.
The 4th step was selected sizeable drip nozzle, with suitable speed, splashed in 40 →-15 ℃ the condensing agent; Condensing agent can be any one or a few in liquid paraffin, methyl-silicone oil, the vegetable oil.
The 5th step type to be shrunk to takes out, and removes the surface condensation agent, drying.
The Danshen root drop pills for treating coronary heart disease preparation that [beneficial effect] is involved in the present invention; utilize substrate such as surfactant polyethylene, polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, stearic acid and medicine material to make solid dispersion; making medicine be molecule, colloid or microcrystalline state is scattered in the substrate; the total surface area of medicine increases; and substrate is hydrophilic; medicine had wetting action; can make that medicine is rapidly molten to loose into microgranule or solution, thereby make the dissolving of medicine and absorb and accelerate.Thereby improved bioavailability, performance is efficient, Stabilization etc.
Compare with the administering mode of tablet, exist essential distinction.Drop pill with the solid dispersion technology preparation can adopt oral and sublingual administration, and effective ingredient is fully contacted with mucomembranous surface, absorbs by mucomembranous epithelial cell, directly enters blood circulation.Especially sublingual administration administration can directly enter blood circulation without gastrointestinal tract and liver, has avoided first pass effect effectively, thereby it is rapid to have an onset, bioavailability height, characteristics such as side effect is little, and medication is convenient.
1. compare with oral tablet, this preparation not only can be oral, but sublingual administration still, this just overcome the tablet onset slowly, shortcoming such as low, the gastrointestinal irritation of liver sausage first pass effect, bioavailability.
2. this dropping pill formulation volume is little, in light weight, more is applicable to and carries.After containing entrance cavity, contact promptly with saliva and to dissolve rapidly, and absorb by oral mucosa, not only rapid-action, and the influence of not taken food, promptly all can containing take after meal ante cibum.
3. the contained drug dose of each drop pill of this preparation is accurate, and the patient who is suitable for the different state of an illness, all ages and classes more flexibly and accurately grasps dosage.
4. the production process equipment for preparing this preparation-drop pill is simple, easy to operate; Operation is few, with short production cycle, automaticity is high, labor intensity is low, production efficiency is high; Workshop does not have dust, helps labor protection and environmental protection; The preparation drop pill need adopt high-tech means and equipment, and principal agent is uniformly dispersed in substrate, and dosage is accurate, and the ball method of double differences is different little than tablet; Production cost is lower than with below 50% of kind tablet.
5. this preparation is by after the heating of solid drugs and substrate, being melt into liquid state, splashes into to make in the not miscible condensed fluid.Therefore, the stability of drug height, not facile hydrolysis, oxidation, and the operation be under liquid state, to carry out, no dust pollution is not subject to the influence of crystal formation, thereby has guaranteed the quality of medicine, has increased stability.
[specific implementation method]
By following concrete embodiment, can further understand the present invention, but following example not a limitation of the invention.
The preparation of embodiment 1-Danshen root drop pills for treating coronary heart disease (1)
Method: taking polyethylene glycol 2,000 0.1 restrains respectively, Macrogol 4000 13 grams, polyethylene glycol 6000 23.5 grams, Polyethylene Glycol 8,000 0.1 grams, cetomacrogol 1000 0 0.1 grams, polyoxyethylene stearate 40 esters 1 gram, betacyclodextrin 0.5 gram, poloxamer 0.5 gram, carboxymethyl starch sodium 0.5 gram, stearic acid 0.1 gram, sodium stearate 0.1 gram, glycerin gelatine 0.1 gram, glyceryl monostearate 0.1 gram, Lac 0.1 gram, polyoxyethylene monostearate 0.1 gram, polyethers 0.1 gram, mix homogeneously, add Radix Salviae Miltiorrhizae again, Radix Notoginseng, Lignum Dalbergiae Odoriferae oil extract raw material 10 grams, fully mix, adopt electrically heated mode with the supplementary material mixture heated that makes to molten condition, adopt homemade special drilling pill machine, regulate its water dropper temperature and make it remain on 85 ℃ (error<2%); With the methyl-silicone oil is condensing agent, the refrigeration control system of regulating the drop pill machine makes the temperature of condensing agent remain on 20 →-5 ℃ (error<5%), again according to the given method of the front preparation technology system of dripping, wait to take out behind the type of being shrunk to, remove the surface condensation agent, drying is made the drop pill that the heavy 50mg of ball contains medicine 10mg/ grain, carry out then rounding rate (%), dissolve scattered time limit (minute), the mensuration of the ball method of double differences different (%) and hardness, the results are shown in Table 1.
The testing result of table 1, Danshen root drop pills for treating coronary heart disease (1)
Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness is qualified
84 8-10 5 Qualified
The preparation of embodiment 2-Danshen root drop pills for treating coronary heart disease (2)
Method: taking polyethylene glycol 4,000 10 grams, polyethylene glycol 6000 20 grams, polyoxyethylene stearate 40 esters 3 restrain respectively, betacyclodextrin 6 restrains, glyceryl monostearate 1 gram, mix homogeneously, add Radix Salviae Miltiorrhizae, Radix Notoginseng, Lignum Dalbergiae Odoriferae oil extract raw material 10 grams again, fully mix, adopt electrically heated mode with the supplementary material mixture heated that makes to molten condition, adopt homemade special drilling pill machine, regulate its water dropper temperature and make it remain on 85 ℃ (error<2%); With the methyl-silicone oil is condensing agent, the refrigeration control system of regulating the drop pill machine makes the temperature of condensing agent remain on 20 →-5 ℃ (error<5%), again according to the given method of the front preparation technology system of dripping, wait to take out behind the type of being shrunk to, remove the surface condensation agent, drying is made the drop pill that the heavy 50mg of ball contains medicine 10mg/ grain, carry out then rounding rate (%), dissolve scattered time limit (minute), the mensuration of the ball method of double differences different (%) and hardness, the results are shown in Table 2.
The testing result of table 2, Danshen root drop pills for treating coronary heart disease (2)
Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness is qualified
84 9-11 4 Qualified
The preparation of embodiment 3-Danshen root drop pills for treating coronary heart disease (3)
Method: taking polyethylene glycol 4,000 11 grams, polyethylene glycol 6000 29 restrain respectively, mix homogeneously, add Radix Salviae Miltiorrhizae, Radix Notoginseng, Lignum Dalbergiae Odoriferae oil extract raw material 10 grams again, fully mix, adopt electrically heated mode with the supplementary material mixture heated that makes to molten condition, adopt homemade special drilling pill machine, regulate its water dropper temperature and make it remain on 85 ℃ (error<2%); With the methyl-silicone oil is condensing agent, the refrigeration control system of regulating the drop pill machine makes the temperature of condensing agent remain on 20 →-5 ℃ (error<5%), again according to the given method of the front preparation technology system of dripping, wait to take out behind the type of being shrunk to, remove the surface condensation agent, drying is made the drop pill that the heavy 50mg of ball contains medicine 10mg/ grain, carry out then rounding rate (%), dissolve scattered time limit (minute), the mensuration of the ball method of double differences different (%) and hardness, the results are shown in Table 3.
The testing result of table 3, Danshen root drop pills for treating coronary heart disease (3)
Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness is qualified
85 8-11 5 Qualified
The preparation of embodiment 4-Danshen root drop pills for treating coronary heart disease (4)
Method: taking polyethylene glycol 6,000 30 grams, ethylene glycol 4,000 7 grams, poloxamer 3 restrain respectively, mix homogeneously, add Radix Salviae Miltiorrhizae, Radix Notoginseng, Lignum Dalbergiae Odoriferae oil extract raw material 10 grams again, fully mix, adopt electrically heated mode with the supplementary material mixture heated that makes to molten condition, adopt homemade special drilling pill machine, regulate its water dropper temperature and make it remain on 85 ℃ (error<2%); With the methyl-silicone oil is condensing agent, the refrigeration control system of regulating the drop pill machine makes the temperature of condensing agent remain on 20 →-5 ℃ (error<5%), again according to the given method of the front preparation technology system of dripping, wait to take out behind the type of being shrunk to, remove the surface condensation agent, drying is made the drop pill that the heavy 50mg of ball contains medicine 10mg/ grain, carry out then rounding rate (%), dissolve scattered time limit (minute), the mensuration of the ball method of double differences different (%) and hardness, the results are shown in Table 4.
The testing result of table 4, Danshen root drop pills for treating coronary heart disease (4)
Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness is qualified
87 9-10 5 Qualified
The preparation of embodiment 5-Danshen root drop pills for treating coronary heart disease (5)
Method: taking polyethylene glycol 6,000 17 grams, ethylene glycol 4,000 20 grams, betacyclodextrin 3 restrain respectively, mix homogeneously, add Radix Salviae Miltiorrhizae, Radix Notoginseng, Lignum Dalbergiae Odoriferae oil extract raw material 10 grams again, fully mix, adopt electrically heated mode with the supplementary material mixture heated that makes to molten condition, adopt homemade special drilling pill machine, regulate its water dropper temperature and make it remain on 85 ℃ (error<2%); With the methyl-silicone oil is condensing agent, the refrigeration control system of regulating the drop pill machine makes the temperature of condensing agent remain on 20 →-5 ℃ (error<5%), again according to the given method of the front preparation technology system of dripping, wait to take out behind the type of being shrunk to, remove the surface condensation agent, drying is made the drop pill that the heavy 50mg of ball contains medicine 10mg/ grain, carry out then rounding rate (%), dissolve scattered time limit (minute), the mensuration of the ball method of double differences different (%) and hardness, the results are shown in Table 5.
The testing result of table 5, Danshen root drop pills for treating coronary heart disease (5)
Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness is qualified
82 10-12 4 Qualified

Claims (5)

1. Danshen root drop pills for treating coronary heart disease is characterized in that described drop pill is made up of the Radix Salviae Miltiorrhizae, Radix Notoginseng, Lignum Dalbergiae Odoriferae extract and the substrate that contain as active constituents of medicine, its proportioning with weight portion count 1: 1~15.
2. dropping pill formulation according to claim 1 is characterized in that: described substrate includes Polyethylene Glycol (2000,4000,6000,8000,10000,20000), polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, stearic acid, sodium stearate, glycerin gelatine, glyceryl monostearate, Lac, polyoxyethylene monostearate, polyethers one or more composition.
3. dropping pill formulation according to claim 1 is characterized in that: described Radix Salviae Miltiorrhizae, Radix Notoginseng, Lignum Dalbergiae Odoriferae extract are the extract of Radix Salviae Miltiorrhizae 200 grams and Radix Notoginseng 200 grams, add the mixture of Lignum Dalbergiae Odoriferae oil 1.75ml.
4. the preparation method that is used for the described Danshen root drop pills for treating coronary heart disease of claim 1 is characterized in that being made of following step:
Step 1 is according to 1: the ratio of (1~15), promptly get a Radix Salviae Miltiorrhizae, Radix Notoginseng, Lignum Dalbergiae Odoriferae extract raw material, and mix with 1 part to 15 parts matrix phase, its mesostroma is by Polyethylene Glycol (2000,4000,6000,8000,10000,20000), in polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, stearic acid, sodium stearate, glycerin gelatine, glyceryl monostearate, Lac, polyoxyethylene monostearate, polyethers substrate any one or a few mix mutually;
Step 2 adopts water-bath, oil bath or other mode of heating, and mixed material is heated to fusion, stirs;
Step 3 is inserted special-purpose drop pill machine, and adjustment water dropper temperature is 70~120 ℃;
Step 4 is selected sizeable drip nozzle, with suitable speed, splashes in 40 →-15 ℃ the condensing agent; Condensing agent can be any one in liquid paraffin, methyl-silicone oil, the vegetable oil;
Step 5 type to be shrunk to takes out, and removes the surface condensation agent, drying, and packing, promptly.
5. according to the step 3 of the described preparation method of claim 4, it is characterized in that: the preferred scope of temperature of dripping dropping-pill machine head in the system process is 80~100 ℃.
CNA2006101526679A 2005-09-26 2006-09-25 Danshen root drop pills for treating coronary heart disease and preparation thereof Pending CN1939406A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2006101526679A CN1939406A (en) 2005-09-26 2006-09-25 Danshen root drop pills for treating coronary heart disease and preparation thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200510104992.3 2005-09-26
CN200510104992 2005-09-26
CNA2006101526679A CN1939406A (en) 2005-09-26 2006-09-25 Danshen root drop pills for treating coronary heart disease and preparation thereof

Publications (1)

Publication Number Publication Date
CN1939406A true CN1939406A (en) 2007-04-04

Family

ID=37958108

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006101526679A Pending CN1939406A (en) 2005-09-26 2006-09-25 Danshen root drop pills for treating coronary heart disease and preparation thereof

Country Status (1)

Country Link
CN (1) CN1939406A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3020395A4 (en) * 2013-07-11 2016-12-07 Tasly Pharmaceutical Group Co Preparation method for traditional chinese medicine micro drop pill and traditional chinese medicine micro drop pill prepared by using the method
US10626077B2 (en) 2013-08-29 2020-04-21 Tasly Pharmaceutical Group Co., Ltd. Salvianolic acid compound T, preparation method therefor, and use thereof
USRE49035E1 (en) 2013-07-11 2022-04-19 Tasly Pharmaceutical Group Co., Ltd. Traditional Chinese medicine composition, and preparation and application thereof
USRE49050E1 (en) 2013-07-11 2022-04-26 Tasly Pharmaceutical Group Co., Ltd. Traditional Chinese medicine composition, and preparation and application thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3020395A4 (en) * 2013-07-11 2016-12-07 Tasly Pharmaceutical Group Co Preparation method for traditional chinese medicine micro drop pill and traditional chinese medicine micro drop pill prepared by using the method
US11013694B2 (en) 2013-07-11 2021-05-25 Tasly Pharmaceutical Group Co., Ltd. Formulation of a micro drop pill and the preparation method thereof
USRE49035E1 (en) 2013-07-11 2022-04-19 Tasly Pharmaceutical Group Co., Ltd. Traditional Chinese medicine composition, and preparation and application thereof
USRE49050E1 (en) 2013-07-11 2022-04-26 Tasly Pharmaceutical Group Co., Ltd. Traditional Chinese medicine composition, and preparation and application thereof
US10626077B2 (en) 2013-08-29 2020-04-21 Tasly Pharmaceutical Group Co., Ltd. Salvianolic acid compound T, preparation method therefor, and use thereof

Similar Documents

Publication Publication Date Title
CN1247241C (en) Liuwei Dihuang dripping pills and its preparation
CN1939406A (en) Danshen root drop pills for treating coronary heart disease and preparation thereof
CN1730030A (en) Snowbell-leaf tickclover dripping pills and its preparation method
CN1943629A (en) Chinese cassia tree bark oil dripping pill and its preparing method
CN100348174C (en) Oral drop pill in use for clearing away heat and toxic material, relieving inflammation and alleviating pain, and preparation method
CN1686389A (en) Danhong drip pill prepared from salvia root and carthamus and its preparation method
CN100348170C (en) Yitongshu drop pill for treating pain and its preparation method
CN1616064A (en) Blood circulation promoting dripping pill for treating cardiocerebral vascular disease
CN1634476A (en) Chinese ephedra and almond containing cough stopping dripping pills and its preparing process
CN112156129A (en) Red lead blood-activating dropping pill and preparation method thereof
CN1872099A (en) Medication for treating cardiovascular diseases, and cerebrovascular disease
CN100358562C (en) Tendril-leaved fritillary bulb loquat drop pills and preparation method thereof
CN100453072C (en) Isatis root drops and preparation thereof
CN100358496C (en) 'Xingnaojing' dripping pills for treating cephalitis and hepatic coma and preparation process thereof
CN1939505A (en) Shengmai drop pill and its production
CN100348171C (en) Yujin drop pill for clearing away the heat-evil and expelling superficial evils and its preparation method
CN1315472C (en) Motherwort dropping pill and its preparing method
CN100382787C (en) Quick acting toothache relieving dripping pills and its preparation method
CN1292738C (en) Ginseng-pilose antler dripping pill for tonifying heart and kidney and its preparing method
CN1686384A (en) Guanxinning drip pill for treating heart disease and its preparation method
CN1939362A (en) Common andrographis herb drop balls and preparation thereof
CN1322853C (en) Qinglianghou drop pill for treating common cold and throat disease and its preparation method
CN1322851C (en) Tripterygium total terpenoids drop pill and its preparation method
CN1294901C (en) Embolism eliminatinging drop pills with qi invigorating, blood flow promoting and collateral dredging function
CN1634487A (en) Dripping pills for treating high blood fat and its preparing method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication